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Protein trafﬁckingPrestin is the motor protein responsible for cochlear outer hair cell (OHC) somatic electromotility.
Eliminating this abundant basolateral membrane protein not only causes loss of frequency selectivity and
hearing sensitivity, but also leads to OHC death. A membrane-based yeast two-hybrid approach was used to
screen an OHC-enriched cDNA (complementary Deoxyribonucleic Acid) library in order to identify prestin-
associated proteins. Several proteins were recognized as potential prestin partners, including vesicle-
associated membrane protein associated protein A (VAPA or VAP-33). VAPA is an integral membrane protein
that plays an important role in membrane trafﬁcking, endoplasmic reticulum homeostasis, and the stress-
signaling system. The connection between VAPA and prestin was conﬁrmed through co-immunoprecipita-
tion experiments. This new ﬁnding prompted the investigation of the interaction between VAPA and prestin
in outer hair cells. By comparing VAPA expression between wild-type OHCs and OHCs derived from prestin-
knockout mice, we found that VAPA is expressed in OHCs and the quantity of VAPA expressed is related to
the presence of prestin. In other words, less VAPA protein is found in OHCs lacking prestin. Thus, prestin
appears to modify the expression of VAPA protein in OHCs. Intriguingly, more prestin protein appears at the
plasma membrane when VAPA is co-expressed with prestin. These data suggest that VAPA could be involved
in prestin's transportation inside OHCs and may facilitate the targeting of this abundant OHC protein to the
plasma membrane.ogy, Feinberg School of Medi-
nue, Chicago, IL 60611, USA.
).
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Outer hair cells (OHCs) are sensory receptor cells exclusively
found in mammalian cochleae. They play an essential role in
increasing sensitivity and frequency selectivity of mammalian hearing
(for review, see [1]). Without OHCs, hearing threshold is elevated by
∼50 dB [2], frequency resolution disappears [3,4], and the ear's
operation is linearized [5]. It is believed that this local mechanical
ampliﬁcation of the cochlear response to sound is associated with
somatic electromotility [6], a unique feature of OHCs. When the
voltage across the OHC's basolateral membrane (BLM) is altered,
OHCs change their length [7] and stiffness [8]. OHC length is also
altered if the voltage change is due to the deﬂection of the
stereociliary bundle (the OHC's mechanosensitive organelle), as it
would be with sound stimulation in situ [9]. The molecular basis for
OHC somatic electromotility is themotor protein, prestin [10]. A seriesof experiments, including molecular biology, cell biology, biophysics,
in vitro and in vivo physiology have demonstrated that prestin is the
motor protein of OHCs and that it is required for cochlear
ampliﬁcation (for review, see [11,12]). For example, OHCs derived
from prestin-knockout (KO) mice [13–15] or OHCs that lack fully
functional prestin [12], lose somatic electromotility, and ∼50 dB of
hearing sensitivity, as well as frequency selectivity.
The distinct function of the OHC is associated with its several
unusual cellular structural features. For instance, the plasma mem-
brane (PM) has an uncommon lipid composition with extremely low
cholesterol. Increasing cholesterol levels in the PM leads to OHC death
[16]. In addition to the unique lipid composition, a high density of
integral membrane proteins is found in the lateral plasma membrane
[17]. In fact, the OHC's PM is densely packed with ∼10 nm protein
particles, with a density estimated from 2500/µm2 to 6000/µm2 [17].
How these abundant protein particles, assumed to be prestin
tetramers [18], accumulate in the lateral membrane of OHCs and
whether the exceptionally high protein content in the PM is related to
the uncommon lipid composition or to the targeting process remain
unknown. Furthermore, prestin is exclusively targeted to the BLM of
polarized cells in both native cells such as OHCs [19], and non-native
cells like CL4 [Zheng, L. et al., unpublished data]. Despite the fact that
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tyrosine-containing (YXXI) and di-leucine motifs [20], little is known
about prestin trafﬁcking, including the involvement of any transport
protein in this process.
VAPA is an important protein involved in protein trafﬁcking. As
ﬁrst discovered in Aplysia californica [21], VAPA proteins are highly
conserved among different species. There are two Vap genes in
mammals: Vapa and Vapb [21]. VAPA and VAPB proteins are
ubiquitously expressed integral membrane proteins associated with
intracellular vesicles, the endoplasmic reticulum (ER) and micro-
tubules [22,23]. In humans, VAPA and VAPB show 63% amino acid
similarity and have common features in their structures such as a
major sperm protein (MSP) domain (∼120 amino acids) at their N-
termini, a coiled-coil structure in the central domain, and a C-terminal
transmembrane domain [23]. Mammalian VAPA is known to interact
with proteins involved in regulation of sterol, lipid biosynthesis and
trafﬁcking. Proteins in this group include the FFAT (two phenylalanine
in an acidic tract)-motif-containing oxysterol-binding protein (OSBP),
the oxysterol-binding protein-related protein (ORP) [24], and the
ceramide transport protein CERT [25]. The MSP domain of VAPA is
known to interact with the FFAT-motif in target proteins and is
partially responsible for targeting lipid-binding proteins to the ER
[26,27]. Mutation of the MSP domain (P56S) of VAPB causes the
formation of large ER aggregates and is believed to be linked to late-
onset amyotrophic lateral sclerosis type 8 (ALS8) [28]. In addition,
VAPA is also known to interact with proteins that do not have the
FFAT-motif, including viral proteins whose transportation from ER to
Golgi is modulated by VAPA [29], and the ER-localized transcription
factor ATF6 (activating transcription factor 6) [30]. Interactions
between VAPA and the other proteins not only allow the efﬁcient
transport of VAPA-associated proteins to their target locations, but
also inﬂuence the associated proteins' function. For example, over-
expression of VAPA in L6 myoblasts attenuates the insulin-dependent
incorporation of GLUT4 into the PM, and this effect can be suppressed
by over-expression of VAMP-2 (vesicle-associated membrane protein
2), another VAPA-associated protein [31]. Thus, interaction between
VAPA and an associated protein can lead to outcomes on other VAPA-
associated proteins, indicating that VAPA can affect many physiolog-
ical functions beyond its role as a transporting protein.
We identiﬁed VAPA as a potential partner of prestin through a high
throughput membrane-based yeast two-hybrid screening [32]. In this
report, we conﬁrm interaction between VAPA and prestin in
mammalian cells through co-immunoprecipitation (co-IP) experi-
ments. By comparing VAPA expression inwild-type (WT) and prestin-
KO OHCs, we discovered that lack of prestin, which is normally
abundantly expressed in OHCs, affects VAPA expression. Additionally,
we examined the possible role of VAPA in prestin transport inside
mammalian cells.
2. Materials and methods
2.1. Antibodies and plasmids
Polyclonal rabbit anti-mPres antibody was raised against the
carboxy terminal motif of the mouse protein as an antigen, which has
been previously characterized [33]. Monoclonal anti-VAPA antibody
was purchased from BD Biosciences (San Jose, CA). Anti-Frizzled3
(FZD3) antibody was purchased from Sigma (St. Louis, MO).
Monoclonal anti-V5 and anti-myc antibodies were from Invitrogen
(Carlsbad, CA). Monoclonal anti-GFP antibody was from BD Bios-
ciences (San Jose, CA). Anti-Na+/K+ATPase antibody was purchased
from Upstate Biotechnology, Lucerne. Anti-HIS and anti-HSC70
antibodies were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA). Monoclonal anti-HA antibody 12CA5 was kindly provided
by Dr. Robert A. Lamb at Northwestern University. Texas Red-X
phalloidin was purchased from Molecular Probes (Eugene, OR).Secondary antibodies, AlexaFluor-488 and AlexaFluor-546 conjugated
anti-rabbit IgG, AlexaFluor-488 conjugated anti-mouse IgM, Alexa-
Fluor-546 conjugated anti-mouse IgG, donkey anti-mouse IgM-HRP,
and goat anti-mouse IgG-HRP were purchased from Invitrogen, Pierce
(Rockford, IL) or Jackson ImmunoResearch (Bar Harbor, ME).
Vectashield mounting media with DAPI was purchased from Vector
(Burlingame, CA). Plasmids encoding GFP-prestin and V5-prestin
were used with GFP- and V5-tags attached to the C-terminus of
prestin, respectively [19,20]. pBK-NmycTecta plasmid encoding the
myc-α-tectorin was kindly provided by Dr. K. Legan and Dr. G.
Richardson of the University of Sussex. HA-HIS-VAPA plasmid was
purchased from GeneCopoeia (Germantown, MA).
2.2. Yeast two-hybrid analyses
Details of this protocol have been described before [32]. In summary,
full-length mprestin (1–744 a.a.) was inserted into the bait-expression
vector pAMBV4 (Dualsystems Biotech, Switzerland) with CUB-LexA-
VP16downstreamof and in framewithmprestin. The bait vector carries
the LEU2 gene for auxotrophic selection. The sequence of the prestin-
bait vector was conﬁrmed through DNA sequencing. Expression of the
mprestin-Cub-LexA-VP16 fusion protein was further veriﬁed by
Western blot analysis with the anti-mPres antibody. Partial Vapa
(244–993 a.a.) or partial Fzd3 (182–356 a.a) was inserted into the
prey expressing vector pDL2-Nx (Dualsystems Biotech) with NubG
upstream of and in frame with Vapa or Fzd3, respectively. The prey
vector carries the TRP1 gene for auxotrophic selection. pMBV-Alg5 is a
negative control-bait construct, which expresses the Cub-LexA-VP16
fusion protein in the correct orientation in the yeast membrane. The
prestin-bait construct and the negative control, pMBV-Alg5, were
transformed into yeast strain NMY51 (MATa his3Δ200 trp1-901 leu2-3,
112 ade2 LYS2::(lexAop)4-HIS3 ura3::(lexAop)8-lacZ ade2::(lexAop)8-
ADE2 GAL4) (Dualsystems Biotech) and grown on leucine selective
plates (SD-L), respectively. A Vapa-prey/Fzd3 prey construct was
transformed into prestin-bait-expressing yeast or pMBV-Alg5 expres-
sing yeast and grown on leucine-tryptophan double selective plates
(SD-LT). Positive interactions were identiﬁed by the ability of yeast to
grow on leucine-tryptophan-histidine-alanine selective plates (SD-
LTHA) in the presence of 2 mM3-aminotriazole, and by β-galactosidase
expression, indicated by theblue color observed in thepresence ofX-gal.
2.3. Immunoﬂuorescence experiments
For cochlear tissue: All surgical and experimental procedures were
conducted in accordance with the policies of Northwestern Uni-
versity's Animal Care and Use Committee and the NIH Safety
Guidelines. Anesthetized mice were cardiac perfused ﬁrst with
phosphate buffered saline (PBS) containing heparin and then ﬁxed
with 4% formaldehyde (EM grade). For cross-section samples, the
cochleae were post-ﬁxed in 4% formaldehyde for 1 hour at room
temperature and placed in 10% EGTA/PBS at 4 °C overnight. The
decalciﬁed cochlear samples were placed in 30% sucrose/PBS and
embedded in cold OCT compound. Samples were cut in 10–20 µm
sections, placed on glass slides, ﬁxed in 4% formaldehyde for 10 min
and blocked at room temperature for 30 min in blocking solution (1%
BSA, 0.2% saponin in PBS). Samples were then incubated with anti-
VAPA (1:50–1:100) or anti-FZD3 (1:200) followed by incubation with
anti-rabbit-IgG/anti-mouse IgM conjugated with AlexaFluor-488
(1:400) and Texas Red-X phalloidin (1:2000). Samples were then
mounted on glass slides with Fluoromount-G (Southern Biotechnol-
ogy Associates, Inc., Birmingham, AL) or Vectashield mounting media
with DAPI and were observed using a Leica confocal system with a
standard conﬁguration DMRXE7 microscope. For whole-mount
samples, EGTA and cryosectioning were omitted from the procedure.
For transfected mammalian cells: Plasmids encoding HA-HIS-VAPA/
GFP-prestin+HA-HIS-VAPA were transiently transfected/co-
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(Qiagen, Valencia, CA) according to the manufacturer's protocol.
Approximately 28 h post transfection, the cells were ﬁxed with 4%
formaldehyde for 10 min. After blocking for 1 h, the cells were incubated
with anti-HA (1:800) or anti-VAPA+anti-HIS antibody for 1 h at room
temperature. Following a brief wash, the cells were incubated with
AlexaFluor-546 goat anti-mouse IgG (1:500) or AlexaFluor-546 goat
anti-rabbit IgG (1:400)+AlexaFluor-488 goat anti-mouse IgM (1:400)
for 30 min. Cells were visualized using the standard protocol described
above.
2.4. Western blot
2.4.1. Whole cell lysates from transfected cells
OK cells were transiently transfected with the plasmids encoding
GFP-prestin and co-transfected with the plasmids encoding GFP-
prestin+HA-HIS-VAPA, respectively. Approximately 28 h post trans-
fection, cells were harvested and lysed in cold lysis buffer (50 mM
Tris–HCl, pH 7.6, 150 mM NaCl, 1% Triton X-100) supplemented with
protease inhibitor cocktail (1:100) and 100 µg/ml PMSF (phenyl-
methylsulfonyl ﬂuoride). Cell debris of insoluble materials was
removed by centrifugation at 10,000×g for 15 min. The proteins
were resolved by 7.5% NEXT-PAGE (New Electrophoresis X'PRESS
Technology, AMRESCO, Solon, OH), followed by immunobloting
where GFP-prestin and HA-HIS-VAPA were detected using anti-GFP
(1:1000) and anti-HA (1:2000) antibodies followed by goat anti-
mouse IgG-HRP (1:5000). Signals were detected using an ECL
chemiluminescent substrate (Pierce, Rockford, IL). The integrated
intensity of prestin bands was measured in arbitrary units using
Kodak Molecular Imaging Software (Version 5.0) as described before
[34].
2.4.2. Plasma membrane (PM) from transfected cells
Transfected OK cells described above were used to isolate PM
using Membrane Protein Extraction kit (BioVision, Mountain View,
CA), a procedure using aqueous two-phase partitioning [35]. Isolated
PM proteins were loaded on NEXT-PAGE, and blotted with anti-GFP
(1:1000) andanti-Na+/K+ATPase (1:1000), respectively. Na+/K+ATPase
is a PM marker detected on OK cells [20].
2.4.3. Cell lysates from cochleae
Cochleae from either WT- or prestin-KO mice were collected in
CelLytic mammalian tissue lysis/extraction reagent (Sigma, St Louis,
MO). After homogenization, samples were incubated on ice for 2 h
and were centrifuged at 10,000×g for 10 min. Protein concentrations
were measured using the Bio-Rad Protein Assay (Bio-Rad Laborato-
ries, Hercules, CA). The same amounts of proteins from WT- and
prestin-KO-cochleae were loaded on NEXT-PAGE. VAPA protein was
detected by anti-VAPA (1:1000). HSC70 was detected by anti-HSC70
(1:2000). HSC70 is a house-keeping protein used as an internal control.
2.5. Co-immunoprecipitation (co-IP)
HEK293T cells were transiently co-transfected with plasmids
encoding V5-prestin and HA-HIS-VAPA, as well as the negative
control V5-prestin and myc-α-tectorin, and allowed to grow an
additional 28 h. Cell lysates (about 1.5 mg total protein) were pre-
cleared by incubatingwith protein A sepharose (Sigma) at 4 °C for 1 h.
The co-IPs were carried out by rocking pre-cleared protein lysates
with either 2 µg of anti-V5 or anti-HA antibody and Protein A
Sepharose beads for either 2 h or overnight at 4 °C. Cell lysates, which
had been transfected with either HA-HIS-VAPA or V5-prestin, were
used as negative controls. Beads were washed three times with lysis
buffer and bound proteins eluted in Laemmli buffer (with 100 mM
DTT). The proteins were resolved by 7.5% NEXT-PAGE. Standard
protocols for Western blot, primary (anti-HA, 1:2000; anti-V5,1:5000; anti-myc, 1:5000) and secondary antibody incubation, and
detection by ECL were then followed.
3. Results
3.1. Yeast two-hybrid analysis identiﬁes VAPA as a potential interacting
partner of prestin
VAPA was identiﬁed as a potential prestin partner through a
membrane-based yeast two-hybrid screen [32]. In order to eliminate
possible false positives, commonly found in yeast two-hybrid assays,
the interaction between prestin-bait and VAPA-prey was further
tested. SD-LTHA selective plates not only produce both the bait and
prey proteins but also show an interaction between them. The yeast
co-expressing VAPA-prey and prestin-bait (Fig. S1B) grew on SD-
LTHA selective plates and turned blue when tested for the activation
of the lacZ gene (data not shown). However, yeast expressing control-
bait and VAPA-prey showed no growth (Fig. S1A). In other words,
VAPA-prey interacts with prestin-bait but not with the control-bait,
indicating that VAPA is a potential interacting partner of prestin.
3.2. VAPA interacts with prestin in mammalian cells
The detection of an interaction between prestin and VAPA in yeast
does not necessarily mean that the same interaction will occur in
mammalian cells, as yeast and mammalian cells differ in many ways.
Therefore, interaction between prestin and VAPA was investigated in
mammalian cells by co-IP experiments. Plasmids encoding V5-prestin
and HA-HIS-VAPAwere transiently co-transfected into HEK293T cells.
As a negative control, plasmids encoding V5-prestin and myc-α-
tectorin were transiently co-transfected into the same cell line. As α-
tectorin localizes to the tectorial membrane (an acellular gel) and
prestin is located at the basolateral membrane of OHCs, an interaction
between them is unlikely in situ. Therefore, α-tectorin was used as a
negative control. Cell lysates were incubated with anti-V5/anti-HA
antibody and protein A sepharose and eluted proteins were run on
NEXT gel followed by blotting with either anti-HA, anti-V5 or anti-
myc antibody. As shown in Fig. 1A (left), VAPA was co-immunopre-
cipitated with prestin when anti-V5was used to pull down V5-prestin
protein and its associated proteins. In contrast, no VAPA signal was
observed in IPs of VAPA-only expressing lysate (lane 4 in Fig. 1A). As
expected, eluted proteins also contain prestin (Fig. 1A, right).
Likewise, prestin was co-immunoprecipitated with HA-tagged VAPA
when anti-HA was used to pull down HA-VAPA protein and its
associated proteins (lane 4 in Fig. 1B, left). The eluted proteins also
contain VAPA as expected (Fig. 1B, right). Together, these data
conﬁrm the interaction between VAPA and prestin in mammalian
cells. For the negative control, α-tectorin was not co-immunopreci-
pitated with prestin when anti-V5 was used to pull down V5-prestin
proteins (Fig. 1C, left) although abundant prestin protein was eluted
from anti-V5-beads (Fig. 1C, right). As expected, both prestin (Fig. 1C,
right) and α-tectorin (Fig. 1C, left) were present in the ﬂow-through.
These data indicate that the lack of co-IP between prestin and α-
tectorin is not due to lack of prestin and α-tectorin proteins. Hence,
these data demonstrate that the interaction between VAPA and
prestin is speciﬁc.
3.3. VAPA and prestin co-localize in OHCs
Our data demonstrate that VAPA interacts with prestin in both
yeast and mammalian cells. Since VAPA is an important protein
involved in protein trafﬁcking [25–29], we suspected that VAPA was
involved in prestin's transportation in OHCs, where prestin proteins
are expressed. Before investigating VAPA protein expression in the
cochlea, the speciﬁcity of anti-VAPA antibody was tested in HEK 293T
cells transiently transfected with HA-HIS-VAPA plasmid using
Fig. 1. VAPA can speciﬁcally bind to prestin. HEK293T cell lysates from HA-VAPA and V5-prestin+HA-VAPA or V5-prestin and V5-prestin+HA-VAPA-expressing cells were
subjected to co-IP with anti-V5 or anti-HA and Protein A sepharose, respectively. A. The co-IP of HA-VAPA and V5-prestin where VAPA was immunoprecipitated with V5-prestin and
VAPA was visualized by anti-HA antibody. The presence of prestin in the eluate was also shown by staining with anti-V5 antibody. Lanes 1 and 2 show proteins from ﬂow-through.
Lanes 3 and 4 are eluates from prestin-anti-V5-beads. B. The co-IP of HA-VAPA and V5-prestin where prestin was immunoprecipitated with HA-VAPA and prestin was visualized by
anti-V5 antibody. The presence of VAPA in the eluate was shown by staining with anti-HA antibody. Lanes 1 and 2 show proteins from ﬂow-through. Lanes 3 and 4 are eluates from
VAPA-anti-HA-beads. C. The negative control. The co-IP of myc-α-tectorin and V5-prestin shows that no α-tectorin was present in the eluate from prestin-anti-V5-beads when
blotted with anti-myc antibody whereas α-tectorin protein is present in the ﬂow-through. The presence of prestin in the eluate was shown by staining with anti V5 antibody.
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similar to that of anti-HIS, which recognizes HIS antigen attached to
VAPA protein (as shown in Fig. S2). These data suggest that anti-VAPA
antibody can recognize VAPA protein. Using this antibody, we
investigated expression patterns of prestin and VAPA in P5 WT-
mice. As shown in Fig. 2, VAPA is widely expressed in the organ of
Corti, while prestin is speciﬁcally located in OHCs. Co-localization of
VAPA and prestin staining appears in yellow color as indicated by the
arrowhead. For better examination, the image corresponding to the
location marked with the arrowhead is given at a higher magniﬁca-
tion (right corner in Fig. 2K). The observation that VAPA co-localizes
with some prestin in OHCs is consistent with the function of a cargo
carrier. However, as a transport protein, VAPA does not always co-
localize with its associated proteins, including prestin.
3.4. VAPA protein content in OHCs alters with prestin expression
Prestin is abundantly expressed only in OHCs, and the time course
of prestin mRNA and protein synthesis corresponds to the emergenceof somatic motility in OHCs [10,36]. Prestin protein is highly produced
during the ﬁrst two weeks of development, more speciﬁcally from
around P5 until about P13 [36]. If VAPA is indeed involved in the
transport of prestin to the PM, in addition to its other cellular
functions, VAPA expression should increase during the time that
prestin is most heavily produced. In order to investigate the effect of
prestin on VAPA expression, we examined VAPA expression by
Western blot using cochleae derived from P10 and P13 WT- and
prestin-KO mice. As shown in Fig. 3A, intensities of the VAPA protein
band in both P10 and P13 prestin-KO cochleae is less compared to P10
and P13 WT cochleae, while intensities of the house-keeping protein
HSC70 bands are similar among WT- and prestin-KO samples. The
integrated intensities of protein bands for VAPA and HSC70 in WT-
and prestin-KO samples weremeasured in arbitrary units using Kodak
Molecular Imaging Software. Fig. 3B shows the comparison of VAPA
expression inWT- and prestin-KO cochleawhere the band intensity of
VAPA is divided by the HSC70 intensities for the respective cochlea.
VAPA expression in WT cochleae is signiﬁcantly more than that in
prestin-KO cochleae (p=0.01, n=2). Thus, it appears that VAPA
Fig. 2. VAPA andprestin co-localize inOHCs. A–C: images of negative controls: noprimary antibodieswere added.D–G: the same group of cellswith prestin staining (E), VAPA staining (F),
and the corresponding phase-contrast image (D) of a whole-mount sample show a cross-section of the organ of Corti. G shows superimposed images of E and F. H–K: the same group of
OHCs with prestin staining (I), VAPA staining (J) and the corresponding phase-contrast image (H) of a whole-mount sample. In K images of I and J are superimposed. Co-localization of
VAPA and prestin staining appears in yellow color as indicated by an arrowhead. The image corresponding to the locationmarkedwith the arrowhead is given at highermagniﬁcation for
better examination (right corner). Red: anti-mPres staining. Green: anti-VAPA staining. A–G: lowmagniﬁcation images: bar length: 75 µm. H–K: highmagniﬁcation images: bar length:
11.9 µm. Cochlear samples were collected from P5WT-mice.
Fig. 3. The expression of VAPA protein is higher in OHCs derived fromWT- than from prestin-KOmice. A. Western blot data collected from P10 and P13 cochleae derived fromWT- and
prestin-KOmice. B. Semi-quantitative analysis of VAPA proteins inWT- and prestin-KOmice. Intensities of VAPA protein bandswere divided by band intensities of house-keeping protein
HSC70. WT cochlea: n=2, prestin-KO cochlea: n=2 (p=0.01). C. Images of individual OHCs (P13) selected from different locations, either WT- (bottom row) or prestin-KO (top row)
mice. D. Quantiﬁcation of VAPA staining vesicles (green spots) inWT- and prestin-KO OHCs and supporting cells. The areas between cuticular plates and nuclei, as indicated by a yellow
border inoneof theWT-OHCs inC,were selectedandmeasuredusingNIH Image J software.Moregreen spots areobserved inOHCs fromWT-mice, independent of cochlear location. In fact,
there is a statistical differencebetweenWT-OHCs andprestin-KOOHCs (p=0.0001; n=13),withWT-OHCshavingmoreVAPA-greendots per area. The blue stainingof somenuclei is due
to themountingof these samples inVectashield containingDAPI. Other samples,mounted in Fluoromount-Gwithout theDAPIdye, haveunstainednuclei. Aﬁxed area in supporting cells of
WT- and KO organ of Corti was selected for counting green spots. In supporting cells, no signiﬁcant difference (p=0.65) was found in VAPA expression between WT- and KO cochlea.
Green: anti-VAPA. Red: Texas Red-X phalloidin labeling actin.
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protein.
Since prestin is an OHC speciﬁc protein (Fig. 2), we focused on
whether this change of VAPA protein expression is present in OHCs.
Immunoﬂuorescence images of individual OHCs selected from
different locations along the P13 cochlea are shown in Fig. 3C. Higher
VAPA expression is seen (denoted by green color) in WT as compared
to prestin-KO OHCs, whereas actin staining (denoted by red color of
Texas Red-X phalloidin) is unaltered. The area between the cuticular
plate and the OHC nucleus, as outlined in one of the WT-OHCs in
Fig. 3C, was measured in pixels using NIH Image J and the green spots,
assumed to be VAPA-containing vesicles, were counted manually
within that area. Counts made between the cuticular plate and the
nucleus were compared between WT- and KO OHCs. Signiﬁcantly,
more green spots per measured area were found in the OHCs from
WT-mice, independent of cochlear location (p=0.0001) as shown in
Fig. 3D. The green spots located around the synaptic region were not
quantiﬁed due to the difﬁculty in separating spots located in OHCs
from those found in Deiters' cells.
VAPA is not an OHC speciﬁc protein. In fact, VAPA is widely
expressed in different cells in the organ of Corti. Fig. 4 shows radial
views of the organ of Corti derived from both P13WT- and prestin-KO
mice. Both VAPA and prestin are synthesized inWT-OHCs at this time.
Fig. 4A and D indicate that VAPA is not only an OHC speciﬁc protein.
Green spots, designating VAPA protein, are also found in supporting
cells such as Deiters' cells (D), pillar cells (P), and neuronal termini in
both WT- and prestin-KO cochleae. As a control, Fig. 4G shows no
green spots when anti-VAPA antibody was not used, indicating that
the green spots in Fig. 4A and D speciﬁcally denote VAPA protein. As
shown in Fig. 4A and D, the intensities and distribution patterns of
green VAPA spots in these supporting cells are similar in WT and
prestin-KO cochleae. Like OHCs, green spots were measured in ﬁxedFig. 4. VAPA expression in the organ of Corti at P13. VAPA staining (anti-VAPA, green spots
However, punctate VAPA staining is absent in the negative control (G), which is not stained w
phalloidin. Actin (Texas Red-X phalloidin) expression is similar in WT (B), KO (E) and in the
columns. Bar length: 23.8 µm. D: Deiters' cells, P: pillar cells.area of supporting cells of WT- and KO cochlea in Fig. 4A and D. As
shown in Fig. 3D, there is no signiﬁcant difference (p=0.65,
approximately 300 spots analyzed from two sets of organ of Corti)
in VAPA protein in supporting cells (SC) derived from WT- and
prestin-KO organ of Corti. These results demonstrate that VAPA
expression is altered only by prestin in OHCs but not in supporting
cells where prestin is absent.
As OHC death is associated with lack of prestin [37], it is possible
that the reduced VAPA expression observed in prestin-KO OHCs is due
to their potentially unhealthy condition. Therefore, we compared the
expression of another potential prestin partner, FZD3 [32], in OHCs
from bothWT- and prestin-KOmice. FZD3 is suggested to be involved
in the planar orientation of hair bundles in hair cells [38,39]. At P0,
when no prestin is expressed in OHCs [10], FZD3 protein (green color)
was found asymmetrically at one proximal edge in both WT- and
prestin-KO OHCs as indicated by the white arrowheads (Fig. 5),
similar to the distributions reported previously [38,39]. In adults,
however, these asymmetrical FZD3 distributions disappear and a
reduced homogenous FZD3 staining is found in cytoplasm, as shown
in Fig. 6A. We have compared FZD3 protein expression at different
developmental stages and found no obvious difference between WT
and prestin-KO cochleae. To be precise, we compared FZD3 protein
expression betweenWT and prestin-KO cochleae by measuring mean
intensities of FZD3-ﬂuorescence in the cytoplasm using NIH Image J.
The area of each cell was selected and measured for mean intensity in
arbitrary units. An area of background from each image was also
selected and measured. The intensity of the background was then
subtracted from the mean intensity. The average intensity of FZD3
from both WT and prestin-KO was then calculated and compared. As
shown in Fig. 6B, there is no signiﬁcant difference in FZD3 intensity
between WT and prestin-KO OHCs, (p=0.11, WT n=15, KO n=14).
Hence, unlike VAPA, FZD3 expression in OHCs is not prestin-) is present in OHCs and in supporting cells in both WT (A) and prestin-KO (D) mice.
ith anti-VAPA primary antibody, but stained with secondary antibody and Texas Red-X
negative control (H). The right column (C, F, I) shows superimposed images of ﬁrst two
Fig. 5. No difference in FZD3 expression from WT- and prestin-KO mice at P0. FZD3 (anti-FZD3, green) is asymmetrically located only at one side of the OHC's proximal edge as
indicated by white arrowheads in both WT and prestin-KO samples. The level and pattern of FZD3 expression are virtually the same for WT and KO cells. However, at this stage of
development, there is no prestin protein in OHCs. Actin is stained with Texas Red-X phalloidin (red).
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suggest that the connection between VAPA and prestin is indeed real.
3.5. VAPA increases prestin membrane targeting
Since the major function of VAPA is involvement in protein
transportation, and we have demonstrated that prestin interacts with
VAPA and affects VAPA's expression level in OHCs (Figs. 1–4), we
suspected that VAPA is involved in prestin trafﬁcking in OHCs.
Unfortunately, a Vapa knockout mouse is not available, so we were
unable to study the inﬂuence of VAPA on prestin's function in vivo.
Therefore, we chose a heterogenous system to investigate VAPA's
inﬂuence on prestin. OK cells, like OHCs, are polarized cells. They also
have a larger cytoplasm-to-nucleus ratio, allowing better determination
of intracellular localization of the transfected protein. OK cells were
transiently transfected with plasmids encoding GFP-prestin and HA-
HIS-VAPA cDNAs. As shown in Fig. 7D, VAPA and prestin were partially
co-localized in the PM of mammalian cell, similar to the pattern
observed in P5 OHCs (Fig. 2). Since protein trafﬁcking is one of VAPA's
major functions, it is likely that this partial co-localization comes from
involvement of VAPA in prestin transport. To examine the involvement
of VAPA in prestin transport, we compared cells transfected only withFig. 6. Adult OHCs show no difference in FZD3 expression in WT and prestin-KO mice. A. FZ
asymmetrical expression is found in adult OHCs. B. Mean ﬂuorescent intensities of FZD3
ﬂuorescence intensity in arbitrary units per cell for WT-OHCs is about 12 (12.2, SD: 3.1), for K
and KO OHCs (p=0.11, n=15 for WT and 14 for KO). Missing OHCs are indicated by an asGFP-prestin and those co-transfected with both GFP-prestin and HA-
HIS-VAPA. Since cells with the single transfection and co-transfection
may have different levels of prestin expression, we ﬁrst compared
amounts of prestin synthesized in these cells. As shown in Fig. 7E, both
samples have three prestin bands representing the non-glycosylated
prestin monomer (the lowest band), the N-glycosylated prestin
monomer (the middle band) and prestin's dimer (the upper band) as
described before [33]. The integrated intensities of all prestin bands in
each sample were measured in arbitrary units using Kodak ID Image
Analysis software [34]. There was no signiﬁcant difference (p=0.55,
n=3) in the amount of prestin protein synthesized in the single
transfected versus the co-transfected cells. However, the difference in
prestin distribution patterns between cells that express only GFP-
prestin and cells that express both GFP-prestin and VAPA is substantial.
As shown in Fig. 7A, inmanyof the prestin-only transfected cells, prestin
is stacked intracellularly with no prestin in the plasma membrane,
whereas in co-transfected cells (Fig. 7B–D), substantial amounts of
prestin are present in the PMalongwith intracellular structures. Inother
words, more prestin proteins are delivered into the PM in the presence
of over-expressed VAPA, indicating a role for VAPA in prestin transport.
To bemore precise,we subjectively classiﬁed cells into two groups: cells
with prestin targeted to the PM, and cells without prestin staining in theD3 (anti-FZD3, green) is located in the cytoplasm of both WT and prestin-KO OHCs. No
staining in the cytoplasmic areas of WT- and KO OHCs outlined in yellow. Average
O OHCs about 11 (10.78, SD: 2.39). There is no statistical difference between WT-OHCs
terisk. Bar length: 23.8 µm.
Fig. 7. Prestin distribution patterns under the inﬂuence of VAPA. OK cells were transiently transfected with GFP-prestin alone (A) or co-transfected with GFP-prestin+HA-VAPA (B,
C). Approximately 28 h post transfection, cells were ﬁxed and incubated with anti-HA antibody followed by the corresponding secondary antibody. The yellow image (right column)
is superimposed from green and red images, indicating the partial co-localization of prestin and VAPA (D) as indicated by the arrow. For better visualization of the co-localization, the
co-localization portion is shown in the right corner at higher magniﬁcation. Bar length: 23.8 µm. A shows that prestin is intracellularly localized in the absence of over-expressed
VAPA, whereas in the presence of over-expressed VAPA (B) prestin is localized to the plasma membrane. E. Comparison of GFP-prestin expression in OK cells transfected with GFP-
prestin alone or co-transfected with GFP-prestin+HA-VAPA. GFP-prestin expression was similar in both GFP-prestin- and GFP-prestin+HA-VAPA transfected cells where GFP-
prestin was visualized using anti-GFP antibody. VAPA was observed using anti-HA antibody. F. Distribution of prestin protein under the inﬂuence of VAPA. OK cells were transfected
with either the plasmid encoding GFP-prestin, or plasmids encoding GFP-prestin+VAPA. OK cells with green staining (prestin) in the PMwere deﬁned as “in the PM” (hatched bars).
OK cells without green staining in the PM were deﬁned as “not in the PM” (black bars). G. More prestin is delivered to the PM in the presence of over-expressed VAPA than in
presence of a control protein, α-tectorin. GFP-prestin was visualized by anti-GFP. Na+/K+ATPase, which is a PM marker, was stained with anti-Na+/K+ATPase.
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experiment) randomly from at least three transfection experiments. As
shown in Fig. 7F, a majority of cells expressing GFP-prestin alone (65%)
did not have green prestin staining in their PM. In contrast, most cells
expressingbothGFP-prestin andVAPAdid showprestin staining at their
PM (60%). There was a signiﬁcant difference (p=0.02, n=3) in the
percentage of cells containing prestin in the PM between single and co-
transfected cells. To restate, more prestin proteinwas delivered into the
PM when VAPA was co-expressed with prestin. Since similar levels of
prestinwere expressed in both single- and co-transfected cells (Fig. 7E),
we rule out the possibility that VAPA expression may simply alter
prestin protein-expressing levels rather than directly affecting protein
trafﬁcking. Thus, the presence of over-expressed VAPA proteins seems
to help prestin successfully translocate into the PM.
To further support this claim, we also used a biochemical method
to isolate the PM from OK cells that were transfected with either HA-
HIS-VAPA+GFP-prestin or those with α-tectorin+GFP-prestin. As
shown in Fig. 7G, more prestin is found in the PM of VAPA+prestin-
transfected cells compared to that of α-tectorin+prestin-transfected
cell. Na+/K+ATPase was used as the PM marker. These data further
support the involvement of VAPA in prestin transport. Two different
methods, biochemical and cellular biology, demonstrate that VAPA
increases prestin delivery to the PM in an in vitro system.
4. Discussion
Prestin is a unique molecular-motor protein exclusively expressed
in the PM of OHCs in the organ of Corti of themammalian cochlea. Due
to its contribution to the OHCs' characteristic somatic electromotility,
it is of interest to ﬁnd proteins that interact with prestin. However,
very few prestin-associated proteins have been described [40]. This is
the ﬁrst report identifying VAPA as an interacting partner for prestinin OHCs. Although this interaction was found in yeast, it was
conﬁrmed in mammalian cells using both co-localization and co-IP
experiments, and further veriﬁed in OHCs.We have also shown that in
mammalian cells the translocation of over-expressed prestin to the
PM, which is analogous to the abundant prestin expressed in OHCs,
increases in the presence of over-expressed VAPA. This gives evidence
of the involvement of VAPA in prestin translocation.
Among the interacting partners of prestin, identiﬁed by the yeast
two-hybrid screen, two-proteins, FZD3 and VAPA were studied here.
We have shown that while FZD3 expression is unaffected in prestin-
KO OHCs, the amount of VAPA expression is somehow related to the
presence of prestin proteins, inasmuch as fewer VAPA proteins are
found in prestin-KO OHCs. It thus appears that prestin regulates the
expression of VAPA protein in OHCs. One possible explanation might
be that abolishing the expression of such an abundant protein, like
prestin in OHCs, could result in a reduced demand for transport
proteins, such as VAPA. However, how prestin regulates VAPA's
expression remains unknown.
From previous studies, it is known that VAPA is involved in
regulating lipid-transfer at the ER-Golgi membrane contact sites by
directly binding certain lipid-transfer and/or lipid-binding proteins,
thereby controlling cholesterol and sphingomyelin production.Our data
provides another example of VAPA's involvement in protein transport.
Further experiments are needed to investigate where and how VAPA is
involved in prestin transport. For now, one cannot rule out the possible
presence of an intermediate protein in this transportation process.
Commonly, the MSP domain of VAPA is known to interact with the
FFAT-motif in the target protein. Interestingly, our results show strong
binding (as shown by both yeast two-hybrid and co-IP analyses)
between VAPA and prestin, yet there is no apparent FFAT-motif in
prestin. So, in addition to Norwalk virus nonstructural protein p48 [29],
prestin is another example of non FFAT-containing proteins that bind to
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difﬁcult to predict which domain of prestin is involved in binding to
VAPA. According to sequence analysis, binding between prestin and
VAPA does not involve the N-terminus MSP domain of VAPA. One may
broadly speculate that the coiled-coil structure (the central domain)
and/or the intracellular membrane anchor at the C-terminus of VAPA
are most likely to be involved in the interaction with prestin.
Recent data suggest that VAP family proteins are not simply cargo
carriers. They are involved in multiple cellular functions, including
membrane trafﬁcking, cytoskeleton association and membrane dock-
ing interactions for ER-localized transcription factor ATF6 [30]. A
single missense mutation (P56S) within the human Vapb gene causes
ALS8, due to the formation of endogeneous VAPB aggregates, which
recruit both WT VAPA and VAPB. Consequently, the reduction in
cytosolic VAP level results in the disruption of binding between WT
VAP-proteins and FFAT-motif-containing proteins, eventually leading
to motor neuron degeneration [28]. In addition, VAPA and VAPB can
interact with and modulate the activity of ATF6 [30], a sensor for the
UPR (unfolded-protein response) signaling cascades expressed in
response to cellular stress and possibly triggering apoptosis [41].
In conclusion, our data demonstrate that VAPA is a novel inter-
acting partner for prestin andmay be involved in prestin translocation
to the plasma membrane. Prestin trafﬁcking in OHCs could involve
many proteins, and VAPA may be one of them. Further studies are
required to understand the molecular mechanism of how prestin
regulates VAPA expression, and how VAPA regulates membrane
composition in OHCs. Understanding the activation mechanism could
eventually help us prevent OHC loss, which is the most common
sensory defect, affecting millions of people ranging from newborns to
the elderly.
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